Atopic dermatitis (AD) is primarily driven by Th2 cells. Although CD3+ T cells and CD11c+ cells predominate in lesional (L) over nonlesional (NL) skin, both sites harbor epidermal dysregulation and a type 2 profile relative to healthy skin. Therapeutics focusing on Th2-mediated pathways partially fill an unmet medical need, highlighting the importance of further characterizing the adaptive and innate immune landscape in L versus NL skin. Paired L and NL biopsies and matched blood samples were collected from 10 patients. The immunophenotype and cytokine profile of immune cells were examined at the single-cell level using multiparameter flow cytometry and unsupervised analysis. L compared with NL skin was predominantly infiltrated by CD4+CD103+PD-1+ tissue-resident memory T cells (TRMs) that positively correlated with disease severity (EASI). CD4+ CD103+PD-1+ TRMs coexpressed CD25 and ICOS. Frequencies of skin-resident CD4+CD103-PD-1+CXCR5+CCR5+/- follicular/peripheral helper T cells (Tfh/Tph) were also augmented in L skin. CCR5- Tfh/Tph coexpressed ICOS, OX40, and IFN-γ along with IL-4 or CD120b while CCR5+ Tfh/Tph coexpressed IL-4Rα. Furthermore, inflammatory monocytes and monocyte-derived dendritic cells (Mo-DCs) positively correlated with CD4+CD103+PD-1+ TRMs and EASI in L skin. These findings enhance our knowledge of AD's innate and adaptive immune profile which may facilitate the discovery of novel therapeutic targets.
Keywords: CD4 T cells; antigen‐presenting cells; dermatology; inflammation; skin diseases/immunology.
© 2025 The Author(s). European Journal of Immunology published by Wiley‐VCH GmbH.